Phase 2 Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Alzheimer's disease or mild cognitive impairment
- People whose score on a standard memory and thinking test (called the MMSE) falls between 10 and 26
- People whose level of dementia-related daily functioning has been rated as 0.5 (very mild) or 1 (mild) on a standard assessment scale (called the CDR)
Who may not be able to join:
- People who score above 4 on a scale used to assess whether memory problems may be related to reduced blood flow in the brain (called the Hachinski Ischemic Score)
- People who have a history of substance abuse or dependence
- People who have Parkinson's disease, epilepsy, or dementia that includes symptoms such as hallucinations or delusions
- People who have been diagnosed with major depressive disorder
- People who have serious physical health conditions
- People who have severe difficulty seeing or hearing
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the Alzheimer's disease assessment scale - cognitive subscale at week 8, 16 and 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.